Observational studyRespiratory research2020

Short-term effects of Lumacaftor/Ivacaftor (Orkambi™) on exertional symptoms, exercise performance, and ventilatory responses in adults with cystic fibrosis.

Bradley S Quon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.